KEROS THERAPEUTICS INC

$KROS

← All companies Sign in to track

Institutional coverage

8 13F filers hold $KROS.

13F holders

8

Insider buys · 90d

3code P

Congress · 90d

0

Smart Money · top-200 alpha cohort

No exposure this quarter

No top-200 alpha managers currently hold $KROS. The institutional holders table below shows the broader 13F picture.

Institutional holders

Top 8 of 8 · Source: 13F-HR

Vanguard Group Inc.

Renaissance Technologies

0.01% of portfolio

ADAR1 Capital Management, LLC

0.13% of portfolio

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Insider activity · last 90 days

50 transactions · 14 filers

20 Aug 2026

▼ SOLD

—

—

S

20 Aug 2026

▼ SOLD

—

—

S

20 Aug 2026

▼ SOLD

—

—

S

20 Aug 2026

▼ SOLD

—

—

S

19 Aug 2026

▲ BOUGHT

—

—

P

17 Jul 2026

▲ BOUGHT

—

—

P

06 Jul 2026

· GRANT

—

—

A

06 Jul 2026

· GRANT

—

—

A

15 Jun 2026

Bienaime Jean Jacques —

▲ BOUGHT

1,000

$10.19

P

11 Jun 2026

Newton Charles W. —

▼ SOLD

550

$10.03

S

04 Jun 2026

Knowles Julius —

▼ SOLD

2,625

$10.73

S

04 Jun 2026

Farzan Nima —

▼ SOLD

2,625

$10.73

S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant · F tax-withhold sale. Insider names link to each individual's expert page.

Congress trades · last 90 days

No Congress trades

No STOCK Act filings reference $KROS in the recent window.

Convergence · $KROS

Pattern cards reflect public SEC EDGAR and Congressional filing data only. Detection uses filing dates; trade execution dates may differ. Past convergence patterns do not predict future returns. Nothing here is investment advice.

Source data: SEC EDGAR · 13F-HR · Form 4 · U.S. House Clerk PTR (disclosures-clerk.house.gov) · Senate eFD (senate.gov) · Last refreshed 17:07 UTC.